Central Nervous System Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Central Nervous System Agents
Volume 20, 3 Issues, 2020
ISSN: 1875-6166 (Online)
ISSN: 1871-5249 (Print)
This journal supports open access
Order Your Article Before Print
ISSN: 1875-6166 (Online)
ISSN: 1871-5249 (Print)
This journal supports open access
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research
Contents
Central Nervous System Agents in Medicinal Chemistry , Volume 18 - Number 1
Biography Open Access
Preface Open Access
Editorial Open Access
Research Article
Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences
, 18(1): 4 - 7Veronica R. Alonso, Jose de Jesus Flores Rivera, Yamel R. Garci, Julio Granados, Thalia Sanchez, Lourdes Mena-Hernandez and Teresa Corona*
DOI: 10.2174/1871524916666160229115047
Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences
Review Article
Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention
, 18(1): 8 - 15Yamel Rito, Ivan Torre-Villalvazo, Jose Flores, Veronica Rivas and Teresa Corona*
DOI: 10.2174/1871524916666160226131842
Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention
Review Article
Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica
, 18(1): 16 - 20Yara D. Fragoso*
DOI: 10.2174/1871524916666151210143548
Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica
Review Article
Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
, 18(1): 21 - 31Dusanka S. Skundric*
DOI: 10.2174/1871524916666161018102254
Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Review Article
Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
, 18(1): 32 - 38Saganuwan A. Saganuwan*
DOI: 10.2174/1871524917666170821115748
Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
Review Article
Astrocyte´s RAGE: More Than Just a Question of Mood
, 18(1): 39 - 48Rodrigo E. Gonzalez-Reyes* and Maria G. Rubiano
DOI: 10.2174/1871524916999160505105121
Astrocyte´s RAGE: More Than Just a Question of Mood
Research Article
Combined Strategy for a Reliable Evaluation of Spinal Cord Injury Using an in vivo Model
, 18(1): 49 - 57Rosa M. Gomez*, Kemel Ghotme, Jackeline J. Nino, Maria Quiroz-Padilla, Daniela Vargas, Andy R. Dominguez, George E. Barreto and Magdy Y. Sanchez
DOI: 10.2174/1871524915666150819104114
Combined Strategy for a Reliable Evaluation of Spinal Cord Injury Using an in vivo Model
Research Article
Diagnostic Value of CRP, Procalcitonin, and Ferritin Levels in Cerebrospinal Fluid of Children with Meningitis
, 18(1): 58 - 62Mohammad R. Shokrollahi, Khalil Shabanzadeh, Samileh Noorbakhsh*, Azardokht Tabatabaei, Zahra Movahedi and Ahmad R. Shamshiri
DOI: 10.2174/1871524916666160302103223
Diagnostic Value of CRP, Procalcitonin, and Ferritin Levels in Cerebrospinal Fluid of Children with Meningitis
Research Article
Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity
, 18(1): 63 - 73Nimisha Jain, Jugnu Jaiswal, Ashish Pathak and Pradeep K. Singour*
DOI: 10.2174/1871524917666170104142033
Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity
Co-Editors
G. Aliev
"GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
(USA)
Biography
View Full Editorial Board
"GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
Biography
Biography of G. Aliev
Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, as a Professor and as a Leading Scientist , Institute of Physiologically Active Compounds. Russian Academy of Sciences.
He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy.
G.S. Hamilton
Biopharma Research Leader, Organic and Medical Chemist, Registered US Patent Agent
Catonsville, MD
(USA)
Biography
View Full Editorial Board
Biopharma Research Leader, Organic and Medical Chemist, Registered US Patent Agent
Catonsville, MD
Biography
Biography of G.S. Hamilton
Dr. Gregory received his bachelor’s and PhD degrees in chemistry from the University of Virginia and worked on the synthesis of complex indole alkaloids. In 1988, he joined Nova Pharmaceuticals Inc. He became the Vice President of Chemistry in 1997.
In 2002, as Vice-President, he joined Artesian Therapeutics in Gaithersburg and designed and patented an IND candidate in a year.
In 2005, he joined MGI PHARMA, as head of the medicinal chemistry. In 2007, he became the Senior Director of Intellectual Property, and in 2008, he worked as senior member of IP group
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Central Nervous System Agents was launched in 2001 and later renamed in 2006 as Central Nervous System Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 1.34
Advertisement
Webmaster Contact: info@benthamscience.net